LSN 3154567 is a nicotinamide phosphoribosyltransferase (NAMPT) inhibitor belonging to the kinase inhibitor class, primarily investigated for its potential in oncology and metabolic disease research due… Read more
LSN 3154567 is a nicotinamide phosphoribosyltransferase (NAMPT) inhibitor belonging to the kinase inhibitor class, primarily investigated for its potential in oncology and metabolic disease research due to its modulation of cellular energy pathways. This category features a selection of reference standards, including structural analogues, metabolites, and related compounds such as FK 866, GNE 617, and OT-82. Analytical laboratories utilize these high-quality materials for impurity profiling, method validation, and rigorous quality control protocols during drug development. By providing access to stable isotope labelled compounds and specific degradation products, this collection supports the precise quantification and identification of analytes in complex matrices. Researchers rely on these well-characterized reference materials to ensure the accuracy and reproducibility of assays involving NAMPT inhibition, facilitating reliable data collection throughout the pharmaceutical research lifecycle.